Peyronie's disease is a fibromatosis of the tunica albuginea. While trauma is believed to be the inciting event, the exact pathophysiology of this condition is unknown. In vitro analysis of cell biology can shed light on the pathogenesis of medical conditions and has been used for many decades as a research tool. We have established a cell culture model, which we have used to study the pathobiology of cells derived from Peyronie's disease plaque tissue. In 10 separate cell cultures derived from different individuals, these cells have demonstrated consistent phenotypic, genotypic and functional alterations. In neither of the control cell cultures, neonatal foreskin fibroblasts and normal tunica-derived fibroblasts have any of the above aberrations been demonstrated. The cells studied have been shown to be fibroblasts in nature with a sub-population of myofibroblasts present in culture. The Peyronie's disease plaque tissue-derived fibroblasts have demonstrated (i) consistent morphologic transformation (ii) increased S-phase on flow cytometry (iii) decreased dependence on culture medium (iv) cytogenic instability (v) excess production of fibrogenic cytokines and (vi) stabilization and dysfunctionalization of p53. Further refinement of this model and future analyses may permit an increased understanding of the pathogenesis of this condition and allow the development of therapeutic strategies.
Introduction
Peyronie's diseases is a fibromatosis affecting approximately 3% of men. 1 -5 It is characterized by scar (plaque) formation in the tunica albuginea of the corpora cavernosa. This plaque, the result of a fibrotic process, leads to penile curvature with functional shortening of the penis and erectile dysfunction. 2, 3, 6, 7 Presenting symptoms include penile pain, curvature and inability to accomplish penetrative sexual relations. Peyronie's disease primarily affects men aged 45 -60 y but may affect men of all ages. The psychosocial implications of Peyronie's disease can be remarkable, with as many as three-quarters of patients reporting psychological disturbances. 3 The condition is associated with other fibromatoses, including Dupuytren's contracture (aponeurotic palmar fibrosis) of the hand and Ledderhose's disease (aponeurotic plantar fibrosis) of the foot, and at a cellular level it shares some features with benign neoplasms such as ovarian fibromata. 4,8 -11 The pathogenesis of Peyronie's disease appears to be multifactorial and has not been fully elucidated. As torqueing of the penis occurs in all men during penetrative sexual relations, one of the conundrums concerning Peyronie's disease is, why is it that such a small population of men manifest plaque formation? While trauma is believed to be the inciting event, 12 many theories have been proposed for the pathogenesis of Peyronie's disease, including, autoimmune factors, 11 -14 excess production of fibrogenic cytokines, 15, 16 impaired fibrin clearance within the tunica 4, 5 and cytogenetic aberrations. 4,5,17 -20 The microscopic appearance of a Peyronie's plaque reveals an increased number of fibroblasts, inflammatory cells and increased amounts of collagen deposited in a disorganized fashion. 21 -23 The concept that some patients may be predisposed to the development of excessive fibromatosis while others are not has led to more recent interest in alterations of the cellular and molecular mechanisms which may play a role in Peyronie's disease. Cell culture models have permitted a more in-depth exploration of such mechanisms. Expanding the knowledge case on a disease process is based in part, upon basic research using either animal or cell culture models. El-Sakka et al have developed a rat model for the study of Peyronie's disease. Injecting cytomodulin, a synthetic heptapeptide with TGF-beta-like properties into the rat penis has been shown to induce an intense fibrotic reaction in both the tunica albuginea and corpus cavernosum. 15, 24 This model is heavily predicated upon the role the TGF-beta plays in the pathogenesis of Peyronie's disease and does not take into account any upstream factors that may play a role in the development of Peyronie's disease plaque. However, the development of such a model permits the research investigator to explore the fundamental mechanisms involved in the fibrogenesis in Peyronie's disease and also enables the evaluation of therapeutic strategies for this condition. A cell culture model, while not perfectly replicating the in vivo environment does ensure that the cells studied are derived from and representative of actual Peyronie's disease tissue. Furthermore, such models allow the ready and reproducible study of Peyronie's disease plaque-derived cells in both a cost-efficient and timeefficient manner. Finally, cell culture models allow the study of different cell lines derived from multiple individuals, thus, permitting investigators to identify any inter-individual variance in the pathobiology of the derived cells.
Cell culture methodology
It is hoped that this treatise will serve as a guide to those workers who are interested in developing cell culture models of Peyronie's disease. The methodology outlined here has served us well and has allowed excellent cell production with reliability and reproducibility of the results presented later.
Patient population
The patients enrolled in these studies and from whom tissue is excised have documented clinically significant Peyronie's disease of greater than 12 months duration. They were enrolled according to an approved Institutional Review Board protocol, prior to the date of their operation for correction of penile curvature or prosthesis placement. They were informed that the amount of tissue excised is approximately the size of a match-stick head and will not interfere with the operation or their postoperative care.
Tissue acquisition
Two tunical samples are taken from each patient, one from the plaque itself and the other from an area of 'normal' tunica remote from the plaque. Using loupe magnification, all fascial tissue and corporal smooth muscle is stripped from both specimens to ensure that the source tissue represents the tunica albuginea alone. The plaque specimen is generally a partial-thickness shave biopsy, while the normal tunical specimen is a full-thickness tunical specimen excised from either the corporotomy site (if prosthetic surgery is being performed) or from the site of the plication surgery (if Nesbit surgery is being performed). The specimens are placed immediately into transport media (RPMI, 10% fetal bovine serum, 10 mM HEPES, ciprofloxacin) and transported directly to the laboratory. Ciprofloxacin has been chosen as the antibiotic because of mycoplasma contamination of some of our early cell cultures. Two types of control tissue has been utilized, neonatal foreskins and tunical tissue excised at the time of reconstructive surgery from young men with congenital penile curvature. All control tissues are handled in an identical manner to the Peyronie's disease tunical tissue.
Cell isolation and culture
Using sterile technique, the tissue is sharply divided into 1 mm 2 fragments. Fragments from normal and plaque tissue are placed into separate 50 ml sterile centrifuge tubes containing a-MEM (JRH Scientific). The cells are then incubated overnight at 37 C in 5% humidified CO 2 . The cells and tissue fragments are collected by centrifugation and washed in fresh tissue culture media. Pieces of digested tissue are placed into 25 cm 2 sterile tissue culture flasks along with cells from the pellet and incubated in tissue culture medium (a-MEM þ 10% fetal bovine serum, 1% glutamine, ciprofloxacin) at 37 C in 5% CO 2 . Tissue culture media is changed at 48 h and every 5 -6 days thereafter. Once they have formed confluent monolayers, the cells are harvested using trypsin=EDTA. After washing, cells for continuous cultures are split 1:3 and grown to confluence. At various passages, cells are stored in RPMI=15% fetal bovine serum=7.5% DMSO at 7 90 C. and at selected later passages were cultured in sterile multi-chamber slides (Corning Inc., Corning, NY, USA) and grown until nearly confluent (observed using an inverted tissue-culture microscope). Slides were washed three times with cold PBS, and were then fixed using either 100% cold methanol (4 C) or 2% paraformaldehyde (15 min at 4 C, freshly prepared in PBS). The cells were then washed in cold (4 C) PBS, and underwent cell permeabilization (100% cold methanol). Slides were again washed three times with cold PBS. Individual chambers were incubated with antibodies to either vimentin (Dako, Carpenteria, CA, USA), cytokeratin (BD Bioscience, San Jose, CA, USA), or smooth muscle specific actin (Dako). All experiments included chambers incubated with appropriate mouse isotope controls at the same final protein concentration as used for primary monoclonal antibodies. Primary antibodies were incubated at 4 C for 60 min, followed by washing three times with cold PBS containing 5% BSA, and incubation with secondary antibody (FITC-goat anti-mouse Ig, final dilution 1:20) (BD Bioscience) for 30 min. Following washing (three times with cold PBS=5% BSA), nuclei were counterstained using propidium iodide (1 mg=ml), and slides were cover-slipped following the addition of anti-fade solution. Chamber slides were viewed using a Zeiss Axioscope fluorescence microscope using epifluorescence illumination. Control cells used for all immunofluorescence experiments included human foreskin fibroblasts at early passage number, derived from several different individuals.
Phenotypic analyses
To date, 10 separate and distinct cell cultures have been successfully established from Peyronie's plaques and eight cell cultures from normal tunical tissue from the same patients with Peyronie's disease. Multiple neonatal foreskin and congenital penile curvature tunica-derived cultures have also been established. Cells with fibroblast-like morphology typically grow out from varying numbers of tissue fragments from neonatal foreskins (Figure 1 ), plaque ( Figure 2 ) and normal tunical tissues from Peyronie's patients. In low passage, plaque-derived cultures, the cells typically demonstrate plump cell bodies with cytoplasmic extensions, and generally grow in a more random fashion, in contrast to the pattern seen for foreskin fibroblasts cultured under identical conditions, which grow in parallel, closely packed cell clusters with a 'swirling' appearance. Cells from later passages of Peyronie's disease plaque-derived tissue exhibited considerable pleomorphism, but underwent consistent morphologic transformation between passages eight and 12, resulting in loss of cytoplasmic extensions, and failure to exhibit contact inhibition with the development of cell foci within culture.
Immunofluorescence analysis has been performed to characterize cells isolated from Peyronie's patients with an emphasis on antigenic markers characteristic of fibroblasts. The results have demonstrated strong staining with anti-vimentin antibodies (Figure 3 ) for normal tunical and plaque-derived fibroblast-like cells. Staining was characterized by a thin web-like pattern extending from the cell membrane to the nucleus, a pattern characteristic of intermediate filaments. Similar staining patterns were seen for normal tunical and plaque-derived fibroblast-like cells, which was similar to the staining pattern seen for foreskinderived fibroblasts stained with anti-vimentin antibodies using identical fixation conditions. Low levels of cytoplasmic staining with antibodies to smooth muscle actin was seen in plaque and normal Peyronie's disease cell culture models JP Mulhall et al Peyronie's derived cells (Figure 4 ), but not in cells derived from foreskin. Actin immunofluorescence was characterized by a diffuse cytoplasmic staining pattern in most cells, with occasional cells demonstrating organized actin microfilaments in both plaque and normal Peyronie's derived cells. Neonatal foreskin-derived fibroblasts were negative for smooth muscle actin expression. Similar patterns of smooth muscle actin expression were seen in Peyronie's derived cells fixed in either para-formaldehyde followed by cold methanol, or in cold ethanol alone, suggesting that the antigen expression patterns seen here were unlikely to be the result of fixation technique. All cells (tunica and foreskinderived fibroblasts) were negative for cytokeratin and desmin expression by immunofluorescence. Together, these results suggest that the cells cultured from both plaque and normal Peyronie's tissues are myofibroblasts, and agree with previously reported results by Somers et al, 20 who used similar techniques to obtain cells from Peyronie's tissues.
This work has been confirmed and extended by the UCLA group, 25 which has recently used Western blotting techniques to confirm the presence of vimentin and a-smooth muscle actin in fibroblast cultures derived from normal human tunica. Furthermore, they showed the presence of a novel growth and differentiation factor from the TGF-beta family, myostatin. The number of cells expressing myostatin increased with passage number. These processes appeared to be inducible by incubating cells with TGF-beta.
Genotypic analyses
Since previous experiments by others in Peyronie's disease and the associated Dupuytren's contracture have indicated macroscopic changes in specific chromosomes, 20,26 -28 we undertook studies of numerical changes in specific chromosomes using flourescent in situ hybridization (FISH). 18, 19 For these studies, we have used probes to chromosomes 7, 8, 17, 18, X and Y (Vysis, Downers Grove, IL, USA). FISH was accomplished using simultaneous hybridization with two different fluorochromelabeled probes FITC (green) plus Cy5 (red). In summary, the number of centromere-specific probes was determined using fluorescence microscopy. On FISH microscopy, control fibroblasts isolated from neonatal foreskins contained two copies of chromosomes 7, 8 17 and 18 ( Figure 5 ). In contrast, all Peyronie's disease plaque-derived fibroblasts studied were aneusomic for chromosomes 7, 8, 17, 18 ( Figure 6 ). Foreskin fibroblasts typically had one copy of chromosomes X and Y. In general, Peyronie's disease cell culture models JP Mulhall et al plaque-derived fibroblasts had no copies of the Y chromosome and were often tetrasomic for the other autosomes that were probed. These chromosomal aberrations were present in plaque-derived fibroblasts in very early passages, as low as passage three. Thus, using Poisson statistics, it is probable that these alterations were present at the commencement of cell culture. The presence of aneusomies in early passage plaque-derived cells, combined with the absence of any cytogenetic instability in either foreskin or normal tunica-derived fibroblasts, suggests that chromosomal instability in Peyronie's disease plaque-derived fibroblasts is not the result of culture artifact and, is therefore, likely to be of significance. Recently, Yamanaka et al assessed DNA isolated fom Peyronie's disease plaque tissue for loss of heterozygosity (LOH) and microsatellite alterations (MSI). 17 Using PCR technology, chromosomes 3, 8 and 9 were selected and 20 different polymorphic markers were used to assess for MSI and LOH. Forty per cent of the patients demonstrated MSI on at least one locus. Likewise, 40% of patients demonstrated LOH on at least one locus. These data confirm that cytogenetic instability is prevalent in Peyronie's disease tissue and that it is probably more widespread throughout the genome than previously demonstrated. Of course, whether, these finding are a cause of an effect in the disease process is currently unknown.
Functional analyses
We have utilized this model to assess Peyronie's disease plaque-derived fibroblasts for: (i) proliferation profiles; (ii) basic FGF (bFGF) expression; (iii) the inhibitory effect of biologic agents; and (iv) cell cycle regulator expression.
Fibroblast proliferation profiles
Determination of cell growth rates has been performed using the MTT assay (Vybrant 2 cell proliferation assay, Molecular Probes, Eugene, OR, USA), with slight modifications. This assay, originally developed by Mossman, 29 is based on the reduction of soluble MTT dye to an insoluble compound (formazan) by mitochondrial dehydrogenases, with subsequent dye solubilization by the addition of SDS (sodium dodecyl sulfate). While the assay generally measures the total number of viable cells present, other enzymes that can retain activity after loss of cell viability (for example, glutathione-Stransferase) can reduce the specificity of this assay.
For the cell growth assays, confluent cells were harvested, counted, and the viability determined by trypan blue dye exclusion. Cells were plated into flat-bottomed microtiter (96-well) plates at a final density of 5610 3 viable cells in 200 ml culture media (MEM þ 10% FCS, ciprofloxacin). This cell concentration was chosen based on preliminary experiments using cell densities between 10 3 and 5610 5 per well, which demonstrated that optimal growth was obtained using this initial cell concentration. All experiments were performed in triplicate, with cells incubated at 37 C in 5% CO 2 in a humidified atmosphere for periods of up to 96 h. Four hours before the termination of cultures, 150 ml of tissue culture media was carefully removed, and replaced with 100 ml phenol-free (RPMI=10%FCS) tissue culture medium and 10 ml of MTT stock solution (12 mM MTT), and incubated for an additional 4 h at 37 C in 5% CO 2 . The times indicated for growth, thus represent the total time of viable culture conditions, as MTT at the concentration used, has minimal effect on cell viability. MTT stock solution (12 mM) was prepared by first dissolving 5 mg MTT in 400 ml methanol. This solution, which was stored at 4 C, was diluted in sterile PBS to a final concentration of 5 mg MTT=ml immediately before addition to cell cultures. Cells in each well were carefully mixed, and the MTT reaction product was solubilized by the addition of 100 ml HCl -SDS solution (1 g SDS in 10 ml 0.01 M HCl). Following overnight incubation at 37 C, absorbance was measured at 595 nm using a microplate reader (Fisher Biotech BT 2000, Pittsburgh, PA, USA).
Low passage Peyronie's disease plaque-derived fibroblasts and neonatal foreskin fibroblasts were plated at increasing cell concentrations from 10 3 to 5610 5 cells per well for periods from 24 to 96 h (Figure 7) . At initial concentrations of 10 3 cells, insignificant levels of MTT dye metabolism were detected, which did not change during the 96 h the cells were in culture. These results suggest that Peyronie's derived cells, like normal fibroblasts, will not grow below a minimal cell density. With increasing initial cell concentration, both plaque- Peyronie's disease cell culture models JP Mulhall et al derived and control fibroblasts showed higher levels of MTT dye metabolism, with the former demonstrating significantly higher cell concentrations. With increasing initial cell concentration, cultures of plaque-derived cells reached a growth plateau, consistent with contact inhibition, which was also seen in foreskin fibroblasts. Overall, these results demonstrate two growth characteristics Peyronie's disease plaque-derived fibroblasts, namely lack of growth below a critical cell concentration, and growth arrest at high cell densities, both classic properties of cells in culture.
In order to evaluate growth requirements by Peyronie's fibroblast-like cells, control foreskin fibroblasts, as well as cells derived from plaque were seeded at an initial concentration of 10 4 cells per microtiter well in different concentrations of fetal calf serum (FCS) from 1% to 10% (final concentration). Cultures were evaluated for overall growth using the MTT assay after a total of 72 h in culture. Both plaque and control fibroblasts demonstrated a pattern of decreased cell growth which was directly proportional to the concentration of FCS in the growth media, with growth in 1% FCS only 50% of that in media supplemented with 10% FCS. Finally, Peyronie's disease plaque-derived fibroblasts have been grown in 0.1% FCS medium further supporting the concept that these cells are biologically transformed. We have never been able to grow neonatal foreskin-derived fibroblasts in 0.1% FCS cell culture medium.
Basic FGF expression
With the demonstration by El-Sakka et al that Peyronie's disease plaques expressed TGF-beta, we were interested in defining the role that other fibrogenic cytokines might play in the pathogenesis of Peyronie's disease. For a detailed methodological outline, we refer the reader to our previously published work. 16 The amount of bFGF was compared between supernatant fluids obtained from plaque, normal tunical tissue, foreskin fibroblasts and culture medium (containing 10% FCS) cultured under similar conditions without cells. Multiple analyses (minimum of three independent replicates) were conducted on all specimens including plaquederived cell lines from five different individuals (Figure 8) .
ELISA analysis demonstrated that plaque-derived cells produced more bFGF (22 AE
C contained 3.53 AE 0.6 pg=ml of bFGF. The mean amount of bFGF produced by the five plaque derived cell lines was significantly greater than that produced by foreskin fibroblast cell lines (P ¼ 0.013), conditioned tissue culture media (P ¼ 0.01), and non-plaque tunicaderived cells (P ¼ 0.02). While the levels of bFGF produced by foreskin fibroblasts are greater than those found in conditioned tissue culture medium, this difference did not reach statistical significance. Thus, these data suggested a role for bFGF in the development of Peyronie's disease plaque.
The inhibitory effect of biologic agents
Because the pathophysiology of Peyronie's disease is so poorly understood, there is no clear consensus on how it should be treated. Numerous conservative (oral and intralesional) therapies have been used in the treatment of Peyronie's disease, including verapamil, colchicine, steroids, and alpha-interferon. 30 -32 The effectiveness of these agents has not been clearly proven. We utilized, the previously outlined model for the culture and quantification of proliferation of fibroblasts to investigate the in vitro Peyronie's disease cell culture models JP Mulhall et al effects of prostaglandin E 1 (PGE 1 ), verapamil, colchicine, and alpha-interferon on the proliferation rates of fibroblasts derived from Peyronie's disease tissue. 33 Cell viability was assayed separately by coincubating cells for 96 h at a concentration of 5000 cells=ml with each biologic agent and staining with trypan blue. For this purpose, PGE 1 , verapamil, colchicine, and interferon were added in concentrations of 7.5 mg=ml, 100 mg=ml, 2.5 mg=ml, and 10 5 IU=ml, respectively. Cells and biological agents were placed into a 10 ml flask and brought to a final volume of 10 ml with 10% FCS. Following trypan blue staining, cells were counted using a hemocytometer. As controls, identical cells were incubated without the addition of biologic agents. The effects of the various agents on plaquederived fibroblasts are reported in Figure 9 . Inhibition is expressed as the percentage reduction in optical density (OD) on spectrophotometry at 96 h when compared to control cells, that is, cells cultured in culture medium alone without biologic agents. Maximum inhibition occurred at 96 h in all cases. Culture of plaque fibroblasts with PGE 1 resulted in inhibition of growth of 72 AE 15% at 10 mg=ml, 60 AE 11% at 7.5 mg=ml and 32 AE 19% at 5 mg=ml. No significant effect was seen at 1 and 0.1 mg=ml. Culture with verapamil resulted in a 75% inhibition of cells at 1000 mg=ml and 74 AE 15% at 100 mg=ml. No significant effect was seen at 50, 25, and 10 mg=ml, respectively. Culture with alpha-IFN resulted in 40% inhibition at a concentration of 10 5 IU=ml, 36% at 10 4 IU=ml, and 17 AE 5% at 10 3 IU=ml. Culture with colchicine resulted in a 58 AE 19% growth inhibition at 2.5 mg=ml and 58 AE 24% at 0.5 mg=ml. The viability of those cells not co-incubated with biologic agents (controls) was 88%. Viability was 87% when co-incubated with colchicine, 70% with PGE 1 , and 65% with interferon-alpha 2b. Cell viability after co-incubation with verapamil was significantly less at 40%. These post co-incubation viabilities represent 99% of controls for colchicines, 80% of controls for PGE 1 , 75% of controls for IFN and 45% of controls for verapamil.
Cell cycle regulator expression
Cell over-proliferation, such as that occurring in malignant neoplasms and Peyronie's disease, may result from promotion by activators, failure of suppressors, or the failure to promote cell death (apoptosis). p53 is intrinsically involved in cell cycle regulation, apoptosis and DNA damage repair pathways. Aberrant p53 function leading to cell proliferation and immortalization has been implicated in several human malignancies. 34 -38 Absence, alteration or loss of function of this protein may allow damaged cells, normally halted from passage through the cell cycle, to pass and proliferate, resulting in unregulated cell replication. In certain circumstances, this may lead to the development of non-malignant conditions such as fibromatoses. Recent work has explored the function of p53 in fibromatoses and although controversy exists in this literature a number of workers have implicated aberrations in the p53 pathway in the etiogenesis of certain benign conditions. 35,37,39 -43 In the normal state, the detection of the p53 protein is difficult due to its very short half-life. 37 Furthermore, p53 does not act in isolation but is under negative feedback control through the action of a variety of downstream elements, two of which are mdm2 and p21. 36 Figure 9 Percentage inhibition of fibroblasts in response to colchicines, verapamil, PGE 1 and interferon a-2b at the doses listed. Per cent inhibition is defined as the percentage reduction in optical density (OD) on spectrophotometry at 96 h when compared to control cells (plaque-derived fibroblasts in culture medium alone). Peyronie's disease cell culture models JP Mulhall et al
The methods used for these experiments are outlined in our previously published work. 44 Cells from all plaque cultures isolated in these experiments expressed variable but clearly measurable levels of p53 protein (Figure 10 ). The immunofluorescence pattern seen for fibroblasts stained with anti-p53 antibodies demonstrated predominantly cytoplasmic p53 protein expression, although nuclear staining was also demonstrated at lower frequency. Neonatal foreskin fibroblasts showed no discernible levels of immunofluorescence above background level when stained with anti-p53 antibodies. While there was some heterogeneity in the expression of cell cycle regulators, all four plaquederived cultures demonstrated clear p53, p21 and mdm2 expression. Foreskin fibroblasts demonstrated measurable levels of p21 but no detectable levels of mdm2. The difference in p53 expression between each individual plaque-derived cell culture and foreskin cells was highly statistically significant (P < 0.001).
Summary
Peyronie's disease involves a multifactorial process, which probably involves penile trauma as the inciting event, leading to alterations in cellular and=or molecular pathways which cause excessive scarring and fibrosis. The elucidation of these cellular and molecular pathways is paramount in completing our understanding of the pathophysiology of Peyronie's disease and has significant implications for the development of effective conservative treatments. To date, numerous local and oral therapies have been investigated with varying results. The basic science behind these therapies remains poorly understood. Consequently, surgical procedures for correction of curvature and insertion of penile prosthesis remain the mainstay of effective treatment for significant long-standing Peyronie's disease. We have established fibroblast cultures derived from Peyronie's and normal tunical tissue, which can be reliably studied using a variety of microscopic, immunohistochemical, flow cytometric and molecular biologic techniques. It is hoped that these and future analyses will lead to a more comprehensive understanding of the pathophysiology of Peyronie's disease, specifically, a more enlightened understanding of those factors that render a sub-population of men more susceptible to this disease process.
